FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2007267910> ?p ?o ?g. }

• W2007267910 endingPage "370" @default.
• W2007267910 startingPage "363" @default.
• W2007267910 abstract "Bertoni G, Sassatelli R, Fornaciari G, Briglia R, Tansini P, Grisendi A, Pedretti G, Beltrami M, Conigliaro R, Pacchione D, Bedogni G. Oral isosorbide-5-mononitrate reduces the rebleeding rate during the course of injection sclerotherapy for esophageal varices. Scand J Gastroenterol 1994;29:363-370.A double-blind, multicenter trial was carried out to assess the effectiveness of isosorbide-5-mononitrate in preventing recurrent variceal hemorrhage during the course of endoscopic sclerotherapy. Seventy-six patients with their first bleeding episode from esophageal varices were randomly allocated, after initial control of hemorrhage, to groups receiving either 50 mg/day oral isosorbide-5-mononitrate retard (37 patients) or an identical placebo (39 patients) until variceal eradication. Sclerotherapy was performed at weekly intervals, and varices were intra- and para-variceally injected with 1% polidocanol until eradication. If rebleeding occurred, additional sclerotherapy was performed. Four (10.8%) patients rebled in the isosorbide group, compared with 15 (38.4%) in the placebo group (p = 0.01). The total number of rebleeding episodes was also significantly lower in the isosorbide group (5 versus 19, p = 0.043), whereas comparison between major versus minor rebleedings was not significant. The median transfusion requirement per bleeding episode was not significantly different in the two groups, although the cumulative number of blood units transfused was over threefold greater (22 versus 70) in the placebo group. Two (5.4%) deaths occurred among isosorbide-treated patients and nine (17.9%) among placebo patients (NS). The number of sclerotherapy sessions and the time required to obtain variceal eradication were also comparable in the two groups. Finally, the nitrovasodilator was well tolerated, requiring withdrawal for severe headache in only one patient. In conclusion, isosorbide-5-mononitrate reduces the rebleeding rate and the number of rebleeding episodes before variceal eradication in patients treated with sclerotherapy." @default.
• W2007267910 created "2016-06-24" @default.
• W2007267910 creator A5008062780 @default.
• W2007267910 creator A5018029490 @default.
• W2007267910 creator A5038287934 @default.
• W2007267910 creator A5040377656 @default.
• W2007267910 creator A5041647890 @default.
• W2007267910 creator A5044170554 @default.
• W2007267910 creator A5046346755 @default.
• W2007267910 creator A5067323471 @default.
• W2007267910 creator A5079689402 @default.
• W2007267910 creator A5080275395 @default.
• W2007267910 creator A5090445455 @default.
• W2007267910 date "1994-01-01" @default.
• W2007267910 modified "2023-10-04" @default.
• W2007267910 title "Oral Isosorbide-5-Mononitrate Reduces the Rebleeding Rate during the Course of Injection Sclerotherapy for Esophageal Varices" @default.
• W2007267910 cites W1582378906 @default.
• W2007267910 cites W1965028082 @default.
• W2007267910 cites W197303752 @default.
• W2007267910 cites W1980298686 @default.
• W2007267910 cites W1994279149 @default.
• W2007267910 cites W1996329002 @default.
• W2007267910 cites W2010292807 @default.
• W2007267910 cites W2014331949 @default.
• W2007267910 cites W2018946904 @default.
• W2007267910 cites W2020902782 @default.
• W2007267910 cites W2021646802 @default.
• W2007267910 cites W2022714877 @default.
• W2007267910 cites W2027459269 @default.
• W2007267910 cites W2036964434 @default.
• W2007267910 cites W2042580269 @default.
• W2007267910 cites W2060123467 @default.
• W2007267910 cites W2067584408 @default.
• W2007267910 cites W2069189893 @default.
• W2007267910 cites W2078987964 @default.
• W2007267910 cites W2082456963 @default.
• W2007267910 cites W2093208911 @default.
• W2007267910 cites W2093472821 @default.
• W2007267910 cites W2095591944 @default.
• W2007267910 cites W2132069560 @default.
• W2007267910 cites W2154593257 @default.
• W2007267910 cites W2167366369 @default.
• W2007267910 cites W2179018470 @default.
• W2007267910 cites W3025344055 @default.
• W2007267910 cites W4293241248 @default.
• W2007267910 cites W51546379 @default.
• W2007267910 doi "https://doi.org/10.3109/00365529409094851" @default.
• W2007267910 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8047814" @default.
• W2007267910 hasPublicationYear "1994" @default.
• W2007267910 type Work @default.
• W2007267910 sameAs 2007267910 @default.
• W2007267910 citedByCount "13" @default.
• W2007267910 countsByYear W20072679102021 @default.
• W2007267910 crossrefType "journal-article" @default.
• W2007267910 hasAuthorship W2007267910A5008062780 @default.
• W2007267910 hasAuthorship W2007267910A5018029490 @default.
• W2007267910 hasAuthorship W2007267910A5038287934 @default.
• W2007267910 hasAuthorship W2007267910A5040377656 @default.
• W2007267910 hasAuthorship W2007267910A5041647890 @default.
• W2007267910 hasAuthorship W2007267910A5044170554 @default.
• W2007267910 hasAuthorship W2007267910A5046346755 @default.
• W2007267910 hasAuthorship W2007267910A5067323471 @default.
• W2007267910 hasAuthorship W2007267910A5079689402 @default.
• W2007267910 hasAuthorship W2007267910A5080275395 @default.
• W2007267910 hasAuthorship W2007267910A5090445455 @default.
• W2007267910 hasConcept C126322002 @default.
• W2007267910 hasConcept C141071460 @default.
• W2007267910 hasConcept C142724271 @default.
• W2007267910 hasConcept C15451672 @default.
• W2007267910 hasConcept C178790620 @default.
• W2007267910 hasConcept C185592680 @default.
• W2007267910 hasConcept C204787440 @default.
• W2007267910 hasConcept C27081682 @default.
• W2007267910 hasConcept C2776915459 @default.
• W2007267910 hasConcept C2777214474 @default.
• W2007267910 hasConcept C2777595160 @default.
• W2007267910 hasConcept C2777819096 @default.
• W2007267910 hasConcept C2778012290 @default.
• W2007267910 hasConcept C2778230777 @default.
• W2007267910 hasConcept C2778492647 @default.
• W2007267910 hasConcept C2778808290 @default.
• W2007267910 hasConcept C2778949068 @default.
• W2007267910 hasConcept C2780950165 @default.
• W2007267910 hasConcept C42219234 @default.
• W2007267910 hasConcept C71924100 @default.
• W2007267910 hasConcept C90924648 @default.
• W2007267910 hasConceptScore W2007267910C126322002 @default.
• W2007267910 hasConceptScore W2007267910C141071460 @default.
• W2007267910 hasConceptScore W2007267910C142724271 @default.
• W2007267910 hasConceptScore W2007267910C15451672 @default.
• W2007267910 hasConceptScore W2007267910C178790620 @default.
• W2007267910 hasConceptScore W2007267910C185592680 @default.
• W2007267910 hasConceptScore W2007267910C204787440 @default.
• W2007267910 hasConceptScore W2007267910C27081682 @default.
• W2007267910 hasConceptScore W2007267910C2776915459 @default.
• W2007267910 hasConceptScore W2007267910C2777214474 @default.
• W2007267910 hasConceptScore W2007267910C2777595160 @default.
• W2007267910 hasConceptScore W2007267910C2777819096 @default.

• next